Akari Therapeutics
NASDAQ: AKTX
$6.51
as on
Akari Therapeutics Stock Performance
as on November 13, 2026 at 2:16 pm IST
Day's Low
Day's High
$6.70$7.67
-2.92%
Downside
17.82%
Upside
52 Week's Low
52 Week's High
$3.02$29.3253.69%
Downside
350.38%
Upside
Akari Therapeutics share price movements today
- Previous Close
- $7.45
- Open
- $7.67
- Volume
- 117.8K
- Market Cap
- $17.0M
- Day's Low - High
- $6.70 - $7.67
- 52 Week Low - High
- $3.02 - $29.32
Akari Therapeutics Historical Returns
- 1 Month Return
- -17.59 %
- 3 Month Return
- -7 %
- 1 Year Return
- -68.71 %
- 3 Year Return
- -95.21 %
- 5 Year Return
- -99.51 %
Akari Therapeutics Stock Fundamentals & Key Indicators
Check Akari Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$17.0M
EPS (TTM)
-1600
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0Industry PE ratio
-3.11
PEG Ratio
0.00
EBITDA
-31.8M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-147.45%
Akari Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Akari Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $17.0M | -99.51% | NA | 0.00% | 0.00% | |
| Neutral | $100.6B | 0.07% | -35.18 | 28.00% | 0.00% | |
| StrongBuy | $48.0B | NA | 68.50 | 88.39% | 0.00% | |
| StrongBuy | $138.7B | 189.72% | 34.93 | 85.57% | 0.00% | |
| Buy | $94.7B | 50.70% | 20.43 | 85.77% | 0.39% |
Stock Returns calculator for Akari Therapeutics Stock including INR - Dollar returns
The Akari Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Akari Therapeutics investment value today
Current value as on today
₹33,199
Returns
Returns from Akari Therapeutics Stock
Dollar Impact
₹1,907 (+1.91%)
Analyst Recommendation on Akari Therapeutics Stock
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Akari Therapeutics. Average target price of $25.5
Akari Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Akari Therapeutics.
What analysts predicted
74.47%UPSIDE
Target Price
$25.5
Current Price
$6.51
Analyzed by
7 Analysts
Target
$25.50
Akari Therapeutics target price $25.5, a slight upside of 74.47% compared to current price of $6.51. According to 7 analysts rating.
Indian Investors' Interest in Akari Therapeutics Stock
Search interest for Akari Therapeutics Stock has decreased by -24% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Akari Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Akari Therapeutics Annual Profit & Loss
All numbers in Millions USD
Akari Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Akari Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Akari Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 826.9% return, outperforming this stock by 895.6%
- NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 229.5% return, outperforming this stock by 324.7%
NEGATIVE IMPACTPrice Dip
In the last 7 days, AKTX stock has moved down by -11.7%
About Akari Therapeutics
| Organisation | Akari Therapeutics |
| Headquarters | 401 East Jackson Street, Tampa, FL, 33602, US |
| Industry | Biotechnology |
| CEO | Abizer Gaslightwala |
Key Management of Akari Therapeutics
Name | Title |
|---|---|
Mr. Abizer Gaslightwala | CEO, President & Director |
Mr. Kameel D. Farag | Interim Chief Financial Officer |
Dr. Satyajit Mitra Ph.D. | Executive Director & Head of Oncology |
Mr. Vatnak Vat-Ho M.B.A. | Chief Business Officer |
FAQs
What is Akari Therapeutics share price today?
Akari Therapeutics share price today is $6.51 as on at the close of the market. Akari Therapeutics share today touched a day high of $7.67 and a low of $6.70.
What is the 52 week high and 52 week low for Akari Therapeutics share?
Akari Therapeutics share touched a 52 week high of $29.32 on and a 52 week low of $3.02 on . Akari Therapeutics stock price today i.e. is closed at $6.51,which is 77.80% down from its 52 week high and 115.92% up from its 52 week low.
What is Akari Therapeutics's market capitalisation today?
Akari Therapeutics market capitalisation is $0.00T as on .
How to invest in Akari Therapeutics Stock (AKTX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Akari Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Akari Therapeutics Stock (AKTX) from India?
Indian investors can start investing in Akari Therapeutics (AKTX) shares with as little as ₹94.2300033569336 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.30 in Akari Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Akari Therapeutics share’s latest price of $6.51 as on November 13, 2026 at 8:46 am IST, you will get 1.5361 shares of Akari Therapeutics. Learn more about
fractional shares .
What are the returns that Akari Therapeutics has given to Indian investors in the last 5 years?
Akari Therapeutics stock has given -99.51% share price returns and 26.25% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?